in Resignations

Enlivex Therapeutics Ltd. CEO Schmuel Hess Resigned

0 Comments

CEO of Nasdaq-Listed Cell Immunotherapy Company Enlivex Steps Down

Enlivex develops cell-based treatments for life-threatening immune and inflammatory conditions, such as graft versus host disease, a post bone marrow transplant complication

Name: Schmuel Hess

Continent: Asia

Country: Israel

Company: Enlivex Therapeutics Ltd.

Position: CEO

Reason: Resigned

Announcement Date: October 01, 2019, 10:00pm

Resignation Date:

Source 1: https://www.calcalistech.com/ctech/articles/0,7340,L-3771329,00.html

Add your submission

Image Video Audio Text Embed

This field is required
Delete

Drop Images Here

or

You don't have javascript enabled. Media upload is not possible.

Get image from URL

Maximum upload file size: 10 MB.

Processing...

This field is required Learn more

This field is required
Delete

Drop Video Here

or

You don't have javascript enabled. Media upload is not possible.

e.g.: https://www.youtube.com/watch?v=WwoKkq685Hk

Add

Supported services:

Maximum upload file size: 20 MB.

Processing...

This field is required Learn more

This field is required
Delete

Drop Audio Here

or

You don't have javascript enabled. Media upload is not possible.

e.g.: https://soundcloud.com/community/fellowship-wrapup

Add

Supported services:

Maximum upload file size: 150 MB.

Processing...

This field is required Learn more

This field is required Learn more

This field is required
Delete

e.g.: https://www.youtube.com/watch?v=DWYrcnehito

Supported services:

Processing...

This field is required Learn more

Report

AsiaCEOEnlivex Therapeutics Ltd.IsraelResignedSchmuel Hess

What do you think?

0 points

Leave a Reply